1058302

AbbVie Inc. — FEI 3009751352

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 2, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
North Chicago, IL (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
673221 CFR 314.80(c)(1)(i)Late submission of 15-day report